Condition: Community-acquired Pneumonia · Sponsor: Biotest
The main objective of the trial is to assess the efficacy and safety of trimodulin as adjunctive treatment to standard of care (SoC) compared to placebo plus SoC in hospitalized subjects with sCAP on invasive mechanical ventilation (IMV). Other objectives are to determine detailed pharmacokinetic (PK) properties of trimodulin in a PK substudy and to determine its pharmacodynamic (PD) properties.
This description comes directly from the study's public registry record.
Patrick Langohr · +491732947122 · patrick.langohr@biotest.com
Claudia Schulte · +4915222801491 · claudia.schulte@biotest.com
Always discuss trial participation with your own doctor first.
| Pulmonary Associates of Mobile, P.C. | Mobile, Alabama, United States | Withdrawn |
| University of California San Francisco-Fresno | Fresno, California, United States | Recruiting |
| UC Davis Health | Sacramento, California, United States | Withdrawn |
| Augusta University | Augusta, Georgia, United States | Withdrawn |
| Sparrow Clinical Research Institute | Lansing, Michigan, United States | Withdrawn |
| William Beaumont Hospital | Royal Oak, Michigan, United States | Withdrawn |
| University of Missouri Clinical Research Center | Columbia, Missouri, United States | Withdrawn |
| Hannibal Clinic | Hannibal, Missouri, United States | Withdrawn |
| Mercury Street Medical Group | Butte, Montana, United States | Withdrawn |
| St. Michael's Medical Center | Newark, New Jersey, United States | Withdrawn |
| Buffalo VA Medical Center | Buffalo, New York, United States | Withdrawn |
| Lenox Hill Hospital | New York, New York, United States | Recruiting |
+ 142 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05722938